Bruno Jactel
Chief Executive Officer at Hypercell Technologies, Inc.
Profile
Bruno Jactel is the founder of Pertinent Eco-Solution, where he currently serves as the Chief Executive Officer since 2020.
He is also the founder of Hypercell Technologies, Inc. Dr. Jactel's former job includes being the Chief Executive Officer & Executive Director at TyraTech, Inc. He also held the position of Chief Strategy & Marketing Officer at Merial, Inc. from 1999 to 2012.
Prior to his professional career, Dr. Jactel worked as an Assistant Professor at École Nationale Vétérinaire d'Alfort.
In terms of education, he completed his undergraduate degree at Ecole Nationale d'Administration in 1993 and pursued graduate and doctorate degrees at Sorbonne Université.
Bruno Jactel active positions
| Companies | Position | Start |
|---|---|---|
Hypercell Technologies, Inc.
 Hypercell Technologies, Inc. Packaged SoftwareTechnology Services Hypercell Technologies, Inc. has developed a proprietary point-of-care diagnostic technology platform that allows for the early identification and management of biological contaminants in the food chain, from production to transformation. The private company is based in Brookhaven, GA and was founded by Bruno Jactel, who has been the CEO since incorporation. Despite advances in vaccines and testing tools, production animal diseases still cost $10 billion in lost productivity and threaten the human population when animal diseases jump to the human species. Food-borne diseases impact 48 million Americans every year and cost the economy more than $55 billion/year. Hypercell's solution is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. | Chief Executive Officer | - |
Former positions of Bruno Jactel
| Companies | Position | End |
|---|---|---|
Merial, Inc.
 Merial, Inc. Pharmaceuticals: MajorHealth Technology Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA. | Sales & Marketing | 2012-11-30 |
| École Nationale Vétérinaire d'Alfort | Corporate Officer/Principal | - |
| TYRATECH, INC. | Chief Executive Officer | - |
Training of Bruno Jactel
| Ecole Nationale d'Administration | Undergraduate Degree |
| Sorbonne Université | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
TyraTech, Inc.
 TyraTech, Inc. Chemicals: SpecialtyProcess Industries TyraTech, Inc. engages in development of non toxic personal care products. The firm also engages in the development, manufacture, marketing, and sale of proprietary insecticide and parasiticide products. It products include insect repellent and equine fly repellent. The company was founded in May 2004 and is headquartered in Morrisville, NC. | Process Industries |
Merial, Inc.
Merial, Inc. Pharmaceuticals: MajorHealth Technology Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA. | Health Technology |
Hypercell Technologies, Inc.
Hypercell Technologies, Inc. Packaged SoftwareTechnology Services Hypercell Technologies, Inc. has developed a proprietary point-of-care diagnostic technology platform that allows for the early identification and management of biological contaminants in the food chain, from production to transformation. The private company is based in Brookhaven, GA and was founded by Bruno Jactel, who has been the CEO since incorporation. Despite advances in vaccines and testing tools, production animal diseases still cost $10 billion in lost productivity and threaten the human population when animal diseases jump to the human species. Food-borne diseases impact 48 million Americans every year and cost the economy more than $55 billion/year. Hypercell's solution is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. | Technology Services |
- Stock Market
- Insiders
- Bruno Jactel
